Oncology

© Getty Images

FDA approval expands Welireg to patients with renal cell carcinoma

By Jonathan Smith

The oral treatment belzutifan, developed by MSD (known as Merck in the US) and branded as Welireg, has received the green light from the US Food and Drug Administration (FDA) for the treatment of an advanced form of renal cell carcinoma (RCC).

Janssen recruits AI startup to develop blood cancer treatments

Janssen recruits AI startup to develop blood cancer treatments

By Jonathan Smith

The UK startup Intelligent OMICS (Intellomx) has launched a collaboration with Johnson & Johnson’s pharmaceutical company Janssen to use artificial intelligence (AI) to discover drug targets for the treatment of blood cancer.

© Getty Images

AARDEX Group named founding member of CancerX initiative

By Isabel Cameron

Adherence specialist AARDEX Group has been announced as a founding member of the CancerX initiative, which aims to bring diverse stakeholders together to drive innovation and improve follow up for cancer patients.

© Getty Images

Roche licenses drug to target cancer DNA damage response

By Jonathan Smith

Roche has entered a licensing and collaboration deal with the U.S. company KSQ Therapeutics to co-develop KSQ’s lead cancer drug, which is designed to sabotage the DNA repair mechanisms of cancer cells.

© Getty Inages

Charm Therapeutics gains investment from NVentures to develop therapeutics for cancer

By Charm Therapeutics gains investment from NVentures for cancer therapeutics

Charm Therapeutics has announced investment from NVentures – NVIDIA’s venture investment arm. This represents a major milestone for Charm and means it will be able to deliver more on its research and development (R&D) activities for novel oncology...

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All